Keith D. Coon Email & Phone Number

Chapel Hill, NC, US

Long Island City, NY, US

Ghent, Flemish Region, BE

Huntsville, Alabama, US

• Senior/executive-level sales specializing in consultative selling for large deals and enterprise-wide partnerships.
• Planned and executed sales and business development activities in Discovery Life Sciences’ top Pharma accounts worldwide for entire product portfolio including biospecimens and biomarker services (genomics, proteomics.
• 129% to plan through December 2021 (#2 in sales revenue company wide)
• Global/Strategic Account Manager of the Year 2021 -> President’s Club
• 133% to plan through December 2022 (#2 in sales revenue company wide)
• Global/Strategic Account Manager of the Year 2022 -> President’s Club

Huntsville, Alabama, US

• Planned and executed sales and business development activities in a large territory of the southwestern and midwestern U.S biotech, pharma, and clinical accounts for Discovery Life Sciences with a specialization in.
• 229% to plan through September 2019

Menlo Park, CA, US

• Planned and executed sales activities in a large territory of southwestern U.S. (CA, AZ, UT, NM, NV, HI) academic, biotech, pharma, and clinical accounts for Pacific Biosciences’ third generation sequencing product.
• #2 in company for total sales in 2018
• Application expertise includes de novo prokaryotic and eukaryotic genome sequencing for individual genotyping and population genetics, metagenomics, RNA isoform sequencing, and targeted sequencing.
• Specializing in long cycle, high revenue, complex sales opportunities.

Waltham, MA, US

• Planned and executed sales activities in San Diego academic, biotech, pharma, and clinical accounts for Life Technologies’ research product portfolio including capital equipment and associated consumables.
• 146% to plan for instrument sales 2014
• 216% to plan for instrument sales 2016
• Product market foci include qPCR, dPCR, Sanger Sequencing, and NGS.
• Application expertise includes sample preparation, pharmacogenomics (PGx), gene expression, SNP genotyping, genotyping by sequencing (GBS), 16S metagenomics, inherited disease screening, pre-implantation genetic.

Bergisch Gladbach, North Rhine-Westphalia, DE

• Planned and executed all sales activities in San Diego academic, biotech, and pharma accounts for Miltenyi Biotec’s research product portfolio including instrumentation, reagents, and microarray services.
• #1 in company for total sales through August 2013
• Winner, Leadership Award 2011 (#3 in company for total sales)
• Increased territory revenue 22% in two years (2011-2012) before territory split.
• Provided on- and off-site technical and application support to Miltenyi Biotec’s customer base.
• Analyzed sales data to identify trends and sales opportunities to drive sales growth.

Phoenix, Arizona, US

• Managed a research lab of up to 5 employees, including post-doctoral fellows and technicians.
• Effectively coordinated human and animal tissue specimen procurement for multiple research projects and a clinical trial.
• Managed multiple research projects, including budgets.
• Published the first whole genome study of the effects of surgery on gene expression.
• Led the team that discovered a potentially novel cancer treatment pathway.
• Co-owner of a pending patent for a potentially novel cancer treatment pathway.

Phoenix, AZ, US

• Managed multiple independent research projects.
• Published 16 peer reviewed manuscripts.
• Performed the first whole genome association study in Alzheimer’s disease.
• Helped pioneer the use of pooling-based genome wide SNP association studies.
• Contributed to the discovery of at least four genes known to contribute to a variety of neurodegenerative diseases.
• Developed a novel method for quantitation of mitochondrial heteroplasmy using microarray-based resequencing.

Ph.D., Molecular And Cellular Biology

M.S., Molecular Biology

B.A., Psychology

Education record

Education record